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Edited by Takashi GojoboriAbstract The recognition of recurrent aberrant regions in can-
cer is important to the discovery of candidate cancer related
genes. Here we ﬁrst constructed a genome-wide gene expression
map of squamous lung carcinoma from the Stanford Microarray
Database. High-resolution detection of aberrant chromosomal
regions was performed by using moving-median method. 84%
(27 of 32) of our results were consistent with the previous studies
of comparative genomic hybridization or loss of heterozygosity.
One overrepresented region in Xq28 was newly discovered to be
related to squamous cell lung carcinoma. These observations
could be of great interest for further studies.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Microarray; Aberrant chromosomal region;
Squamous cell carcinoma; Gene expression map;
Moving-median method1. Introduction
Lung cancer is one of the leading causes of cancer death in
the world (Death rate extrapolations in USA for lung cancer:
160,439 per year). Non-small cell lung cancer (NSCLC), the
major form of lung cancer, accounts for nearly 80% of the
disease and consists of three subtypes, squamous cell lung
carcinoma (SCC), lung adenocarcinoma and large cell carci-
noma [1]. Through comparative genomic hybridization
(CGH) and loss of heterozygosity (LOH) analyses, it was
found that the chromosomes of lung tumor tissues often have
recurrent abnormal regions. Consequently, the gene expression
levels in these regions are usually upregulated or downregu-
lated. Deﬁnition of such aberrant regions is one important
route to the identiﬁcation of genes that play a role in NSCLC.
CGH, however, has a limited (20 Mb) mapping resolution.
Meanwhile, high-throughput LOH and ﬂuorescence in situ
hybridization (FISH), as higher-resolution techniques, are
prohibitively labour-intensive on a genomic-wide scale.
Recently a microarray technique, called arrayCGH, has
been used to determine the DNA copy number variation. Pol-*Corresponding author.
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doi:10.1016/j.febslet.2006.04.043lack et al. [2] used microarray containing more than 3000
cDNA probes to localize the genomic aberrations in cancer.
High throughput gene expression analysis techniques were also
used to determine the aberrant regions in cancer. Takeshi Fujii
et al. [3] constructed a transcriptome map based on the serial
analysis of gene expression (SAGE) data to identify the geno-
mic alteration regions in NSCLC. However, the SAGE results
were subject to the size and reliabilities of the SAGE libraries.
In this study, we will introduce a bioinformatics approach for
the generation of gene expression map and detection of the
aberrant chromosomal regions in SCC based on public micro-
array datasets.2. Materials and methods
2.1. Data collection
A normalized microarray dataset, generated in a previous study by
Arindam Bhattacharjee et al. [4], was obtained from http://www.geno-
me.wi.mit.edu/MPR. The dataset contained gene expression data of
lung specimens hybridized to Aﬀymetrix human U95Av2 oligonucleo-
tide arrays, including 21 SCC samples and 17 normal ones.
2.2. Statistical analysis
To identify the diﬀerentially expressed genes, signiﬁcance analysis of
microarrays (SAM) [5] was applied as a method for two-sample t-test
with the estimation of false discovery rate (FDR). Bioconductor
(http://www.bioconductor.org) module, siggene, and the R software
(ver. 2.1.1) [6] were used to perform SAM analysis, and the parameter
delta was set to 1.0. Those genes with FDR < 0.06 were selected for
further analysis.
2.3. Expression ratio calculation
The gene expression ratios of tumor over normal or vice versa were
calculated as follows. First, the hybridization signal intensities of all
cases were termed X1, X2 . . . Xr, whose mean was X ¼ ðX1þ . . .
þXrÞ=r. Fold change for upregulated genes was calculated as
ER ¼ X tumor=X normal and fold change for down-regulated genes was
calculated as ER ¼ X normal=X tumor.
2.4. Gene mapping
AMySQL database was created on Red Hat Linux System (ver. 9.0)
containing the NCBI (National Center for Biotechnology Information)
public databases for genes (ftp://ftp.ncbi.nih.gov/gene/DATA, ftp://
ftp.ncbi.nih.gov/repository/UniGene, dated October 2005) and UCSC
GoldenPath hg17 genome database (http://genome.ucsc.edu/golden-
Path/hg17/bigZips). Each gene’s physical map position in the genomeation of European Biochemical Societies.
Fig. 1. The ﬂowchart of the pipeline of this analysis.
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human genome by using the blat algorithm (http://genome.ucsc.edu/
cgi-bin/hgBlat), with parameters ‘‘-noHead -out=psl -ﬁne -oneOﬀ=1 -
t=dna -q=rna -tileSize=11 minIdentity=95’’. Splicing variants were uni-
ﬁed to one unique gene by using the gene2 accession ﬁle from the NCBI
gene database. UCSC databases (http://hgdownload.cse.ucsc.edu/gold-
enPath/hg17/database) were used to obtain the structure information of
each genome element. The gene expression map was drawn by using the
pdf modules of the Perl language (ver. 5.8.1).
2.5. Detection of diﬀerentially expressed chromosomal regions
A modiﬁed moving-median ratio method [2,3] was used to survey
the gene expression map and to identify the overrepresented or under-
represented chromosomal regions in SCC. The median expression ratio
was calculated for a window size (W) of three positionally consecutive
gene loci. A clustering of diﬀerentially expressed genes was deﬁned as
nine or more runs (R) of consecutive moving-medians with a threshold
cutoﬀ (K) of 1.2 times the genomic median. If the physical map dis-
tance of two ordinal genes was more than 5M base pairs, it was re-
garded that the distance overstepped the allowed cluster size and the
computation of clusters would be renewed from the next three adjacent
genes.
The ﬂowchart of this analysis was shown in Fig. 1.3. Results and discussion
3.1. Statistical analysis and the gene expression map generation
In total 3409 transcripts were ﬁltered from the 12,600 array
probes through the two-sample t-test SAM analysis. From
those screened transcripts, 2721 unique genes were successfully
mapped to the human genome. A high-resolution genome-
wide human gene expression map covering these genes was
constructed (see supplementary ﬁle ArrayScc.pdf).3.2. Diﬀerentially expressed chromosomal regions detected in
squamous cell carcinoma
The moving median tends to reduce variability in genes’
expression ratios, making the expression ratios trend easier
to analyze along each chromosome. Parameter K was set as
a threshold value to ﬁlter the gene expression ratios. A relative
lower K value, 1.2, was used because all the genes were already
identiﬁed signiﬁcantly expressed by the t-test analysis. The size
of moving window was set at 3 so that in a deﬁned aberrant
region there were not two consecutive genes having opposite
expression patterns to most of the remaining genes, and there-
fore increasing the speciﬁcity. When the parameter R was set
to 8, 9 or 10, a total of 43, 31 or 24 regions could be gained,
respectively, for SCC. We applied a mediate R value, 9, in or-
der to optimize both the speciﬁcity and accuracy of the result.
Table S1 (see supplementary ﬁle TableS1.xls) shows the
identiﬁed chromosomal regions in SCC. The genes that were
located within the regions and signiﬁcantly expressed in SCC
were also deﬁned. Of the 32 identiﬁed aberrant regions, 20
were underrepresented while 12 overrepresented. The data of
lung adenocarcinoma was also analyzed but failed to present
meaningful result (data not shown). Of the 27 aberrant regions
detected in lung adenocarcinoma, all appeared to be overrep-
resented. Similar result had been reported by Takeshi Fujii
et al. [3]. The reasons might include: (i) the expression proﬁle
of adenocarcinoma was very similar to normal lung, and had
been testiﬁed in hierarchical analysis of the same datasets by
previous study [4]; (ii) the subclasses of adenocarcinoma were
so various that it was diﬃcult to ﬁnd the distinct expression
proﬁles without further classiﬁcation of adenocarcinoma.
For these reasons, our discussion was focused on SCC.
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chromosome arms 3p and 3q, respectively. As expected, the
expression bars were green for most genes on 3p (representing
downregulation), while on 3q they are mostly red (representing
upregulation) (Fig. 2). Similar scenes can be observed in other
frequently aberrant chromosomal regions such as 8p21 and
20p12. Our analysis might not include some less signiﬁcant
aberrant regions because: (i) the 12,600 expressed transcripts
representing approximately 9000 unique genes cannot cover
all the expressed genes; (ii) some aberrant regions may contain
less diﬀerentially expressed genes. It could be improved by
using larger-scale microarray containing more probes or
reducing the parameters R with sacriﬁce of speciﬁcity.
Previous CGH, FISH and LOH studies from published re-
ports were used to roughly verify our results of aberrant re-
gions in SCC. About 84% (27 of 32) of our results are
consistent with the recurrent aberrant regions, namely, 1p36
[7], 1p35 [8], 3p [9], 4q22 [10], 5q [11], 6p21.3 [12], 8p21–22
[13], 9p21 [10,14], 10q22 [15], 11p15.5 [16], 11q13 [17], 11q22
[18], 12p13 [19], 15q [20,21], 16p [22], 17p13 [23,24], 17q12–
21 [23],17q23 [25] and 19p13.3 [26] are often underrepresented,
while 1q21 [27], 2p13 [28], 2p14–16 [22], 2q24–q31 [29], 3q [30],
7p15–14 [31], 7q11 [20], 20q12–13 [32] and 22q11–13 [33], are
frequently overrepresented. Because of the low resolutions of
the previously developed techniques, those reported aberrant
regions normally have large sizes. Our work narrows down
these regions, and the signiﬁcantly diﬀerentially expressed
genes in the regions are identiﬁed. Our results showed thatFig. 2. Gene expression map of chromosome arms 3p and 3q in squamous ce
view of a small part of the picture to demonstrate the condensation of the pic
supplementary data ﬁle, ‘‘FigS1.pdf’’. The aberrant regions and the informat
band and the expression ratio and pattern of genes were shown orderly from17q21 contained both overrepresented and underrepresented
regions, and the former mainly contained the KRT family
genes, seven of which were upregulated in SCC according to
our result. Similar results were also reported previously
[23,34]. In the remaining ﬁve results, 1 region, 7q21–q22, had
been contrarily reported for to be underrepresented and over-
represented from diﬀerent groups; 3 regions, 1p35, 1q23 and
12q13.11–13.13, were inconsistent with the previous reports,
and this may be due to the diﬀerent resolution between tradi-
tional methods and our analysis.
One new overrepresented region, Xq28, was ﬁrstly discov-
ered in SCC from our analysis. Xq28 had been reported having
relation to tumor carcinogenesis. High-level DNA ampliﬁca-
tions in this region were identiﬁed in mantle cell lymphomas
[35], human breast cancer [36] and adenoid cystic carcinoma
of the salivary gland [37]. Another report indicated that
Xq28 was one of the regions of clustered expression of groups
of adjacent genes, which were co-regulated by transcriptional
activation in major epithelial malignancies in human [38].
In this study, a part of Xq28 (Fig. 3), containing 4,418,626
base pairs, was disclosed as a signiﬁcantly overrepresented re-
gion in SCC. It includes 14 known diﬀerentially expressed
genes, of which 12 were over-expressed. The expression proﬁles
of the 12 genes in normal lung and SCC tissues were shown in
Fig. S1 (See supplementary ﬁle FigS1.xls). Four of the 12 over-
expressed genes, namely MAGEA1, MAGEA2, MAGEA4,
and MAGEA12, were in the MAGEA family. The MAGEA
family consists of 12 genes (MAGEA1 to MAGEA12) andll lung carcinoma. We have added an inset picture to show the enlarged
ture, and meanwhile, the complete high-resolution picture is shown in a
ion of chromosomal position, accession numbers, symbols, cytogenetic
left side to right side.
Fig. 3. Gene expression map of cytogenetic region Xq28 in squamous cell lung carcinoma.
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GEA3, MAGEA4, MAGEA6 and MAGEA12 were reported
to be expressed in melanomas and other cancers but silent in
normal tissues [39]. The results of our studies were highly con-
sistent with those from previous reports, and strongly suggest
that this overrepresented region in Xq28 have signiﬁcant cor-
relation with lung tumor carcinogenesis and may be of great
value for oncologists’ further investigation.Acknowledgements: The authors thank for the help and documentation
of Li Tiantian and Zhang Ke. This work is supported by the Key Pro-
ject of Chinese Ministry of Education (No. 104232), Trans-Century
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